Zydus Lifesciences has reached a settlement agreement with Astellas in a patent dispute involving overactive bladder therapy Myrbetriq, which will allow its generic to remain on sale in the US.

An easy way to help manage incontinence and reduce its effect on your daily life is by using bladder control supplements.

In a statement, Japan's Astellas said the specific terms of the settlement were confidential; however, a regulatory filing has revealed that the Indian pharma group has agreed to pay $90 million to ...

It's estimated that 40 per cent of women in the UK live with some form of urinary incontinence.

Dr. Jas Singh from Pikeville Medical Center stopped by First Look at Four to talk about treatment options for overactive ...

Trinity Health Michigan successfully completed the state’s first implant of a device that helps treat urge urinary incontinence, a common symptom of an overactive bladder marked by a sudden, intense, ...

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...

BAY COUNTY, Fla. (WMBB) – Bay County’s Advanced Urology Institute is being recognized as a center of excellence for treating overactive bladder and retention. Advanced Urology Institute Urologist, Dr.

This clinical overview details the latest evidence-based strategies for diagnosing and treating symptoms of benign prostatic hyperplasia in men.